OCREVUS® (ocrelizumab) Pregnancy Registry
Do you have multiple sclerosis (MS) and are you pregnant? Then you may be able to take part in a global registry of women with MS who are pregnant and either have or have not received OCREVUS® (ocrelizumab) during or within 6 months before their pregnancy.
About pregnancy and multiple sclerosis
The effects of a particular medicine on the health of an unborn baby are often unknown because pregnant women are not usually included in clinical research studies to test a potential new medicine. Pregnancy registries aim to collect information that could help women and their healthcare providers make more informed decisions about using a particular medicine during pregnancy in the future.
Do you have multiple sclerosis (MS) and are you pregnant? Then you may be able to take part in a global registry of women with MS who are pregnant and either have or have not received OCREVUS® (ocrelizumab) during or within 6 months before their pregnancy.
